Is low molecular weight heparin effective for preventing venous thrombosis in hospitalized cancer patients?
Evidence shows that low molecular weight heparin is effective in preventing venous thromboembolism in hospitalized cancer patients, reducing the risk of thrombotic events without significantly increasing major bleeding risks when appropriately managed.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-18
- DOI
- https://doi.org/10.5281/zenodo.24344196
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00